Quick Answer
UroGen Pharma Ltd. reported Total Revenue of $109.79 million for fiscal year 2025.
UroGen Pharma Ltd. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $109.79M | +21.4% |
| 2024 | $90.40M | +9.3% |
| 2023 | $82.71M | +28.5% |
| 2022 | $64.36M | +34.0% |
| 2021 | $48.04M | +307.2% |
| 2020 | $11.80M | +65450.0% |
| 2019 | $18.0K | -98.4% |
| 2018 | $1.13M | -86.2% |
| 2017 | $8.16M | -53.5% |
| 2016 | $17.53M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $27.48M | +9.0% | +13.5% |
| June 30, 2025 | $24.21M | +10.8% | +19.6% |
| March 31, 2025 | $20.25M | +7.8% | -19.6% |
| September 30, 2024 | $25.20M | +20.9% | +15.4% |
| June 30, 2024 | $21.85M | +3.4% | +16.3% |
| March 31, 2024 | $18.78M | +9.2% | -9.9% |
| September 30, 2023 | $20.85M | +29.5% | -1.4% |
| June 30, 2023 | $21.14M | +27.3% | +23.0% |
- UroGen Pharma Ltd. showed an increase of +21.4% in Total Revenue compared to the prior fiscal year.
- Over the 2016–2025 period, UroGen Pharma Ltd.’s total revenue has grown by 526.3% (from $17.53 million to $109.79 million).
- The most recent figure is from UroGen Pharma Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: